Cardinal Health to Buy AssuraMed for $2 Billion


Cardinal Health today announced plans to purchase AssuraMed, a privately held leading provider of medical supplies by mail with approximately $1 billion in annual revenues. The transaction calls for Cardinal to purchase AssuraMed for either $2.07 billion or $1.94 billion; the exact purchase price will be determined based on the value of existing tax benefits.

According to George Barrett, CEO of Cardinal Health, "The acquisition of this industry leader allows us to serve the growing number of Americans treated in home settings -- particularly those patients recovering from acute episodes and those suffering with chronic diseases."

Cardinal expects the acquisition to be completed by April, which would result in expected accretion of $0.02 to $0.03 per share in fiscal 2013, rising to $0.18 a share by 2014. The deal will be funded by $1.3 billion in new debt and approximately $700 million in cash.

Shareholders of AssuraMed have already approved the deal, though the transaction is dependent on standard closing conditions and regulatory approvals.


The article Cardinal Health to Buy AssuraMed for $2 Billion originally appeared on

Fool contributor Tim Brugger has no position in any stocks mentioned. The Motley Fool owns shares of Bank of America. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.